HAO — Haoxi Health Technology Income Statement
0.000.00%
Last trade - 00:00- $2.98m
- -$2.24m
- $32.80m
Annual income statement for Haoxi Health Technology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.8 | 16.2 | 28.2 | 48.5 | 32.8 |
| Cost of Revenue | |||||
| Gross Profit | 0.606 | 0.649 | 2.06 | 2.75 | 0.928 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 12.5 | 15.9 | 27 | 46.8 | 34.8 |
| Operating Profit | 0.331 | 0.269 | 1.2 | 1.72 | -2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.325 | 0.26 | 1.19 | 1.74 | 4.15 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.304 | 0.245 | 0.97 | 1.29 | 3.88 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.304 | 0.245 | 0.97 | 1.29 | 3.88 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.304 | 0.245 | 0.97 | 1.29 | 3.88 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 30.5 | 24.6 | 97.4 | 135 | 207 |
| Dividends per Share |